US 7498353
Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
granted A61PA61P1/16A61P31/12
Quick answer
US patent 7498353 (Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P1/16, A61P31/12, A61P31/14